FGEN - the drama never ends. AZN release states FDA requested Adcom vs sponsors requesting Adcom and I am not sure if that matters. The additional clarifying analysis done since 12/18/20 must have been a waste of time. Question is whether it was BB or CR for NDD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.